Literature DB >> 29767861

Serum expression level of cytokine and chemokine correlates with progression of human ovarian cancer.

J H Luo, C Y Zhang, C Y Lu, G H Guo, Y P Tian, Y L Li.   

Abstract

OBJECTIVE: This work was designed to determine the relationship between serum expression level of cytokines and chemokines and progression of human ovarian cancer, and to evaluate the utility and diagnostic value of target markers as risk indicators.
MATERIALS AND METHODS: A set of candidate cytokines and chemokines (GM-CSF, IFN-γ, GRO, IL-1β, IL-2, IL-6, IL-8, MCP-1, TNF-a, VEGF, EGF, RANTES, CCL21/6Ckine, and SDF-1/CXCL12) were measured using Luminex liquid chip technique in healthy women (n=75) and in women with ovarian cancer (n=77).
RESULTS: EGF, IL-6, MCP-1, 6Ckine, RANTES, and IL-10 were significantly overexpressed in the tumor group compared to those in normal controls, while IL-2 was reduced. The combined markers (EGF, MCP- 1, 6Ckine, IL-6, and TNF-α) achieved 91.1% sensitivity, 65.8% specificity, and 83.3% area under the ROC curve (AUC) in distinguishing serous ovarian cancer from health controls.
CONCLUSION: This study suggested that serum expression level of cytokines and chemokines correlate with progression of human ovarian cancer. The association of EGF, MCP-1, 6Ckine, IL-6, and TNF-α may contribute to increase diagnosis rate of malignant ovarian tumors.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29767861

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  4 in total

1.  SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery.

Authors:  Siwen Hu-Lieskovan; Srabani Bhaumik; Kavita Dhodapkar; Jean-Charles J B Grivel; Sumati Gupta; Brent A Hanks; Sylvia Janetzki; Thomas O Kleen; Yoshinobu Koguchi; Amanda W Lund; Cristina Maccalli; Yolanda D Mahnke; Ruslan D Novosiadly; Senthamil R Selvan; Tasha Sims; Yingdong Zhao; Holden T Maecker
Journal:  J Immunother Cancer       Date:  2020-12       Impact factor: 13.751

2.  Development of a Multiprotein Classifier for the Detection of Early Stage Ovarian Cancer.

Authors:  Kristin L M Boylan; Ashley Petersen; Timothy K Starr; Xuan Pu; Melissa A Geller; Robert C Bast; Karen H Lu; Ugo Cavallaro; Denise C Connolly; Kevin M Elias; Daniel W Cramer; Tanja Pejovic; Amy P N Skubitz
Journal:  Cancers (Basel)       Date:  2022-06-23       Impact factor: 6.575

3.  Interleukin-6 as a biomarker in patients with hepatobiliary cancers.

Authors:  Rohit Gosain; Sidra Anwar; Austin Miller; Renuka Iyer; Sarbajit Mukherjee
Journal:  J Gastrointest Oncol       Date:  2019-06

4.  A Novel Combined Conjugate Therapeutic Cancer Vaccine, Recombinant EGF-CRM197, in Patients With Advanced Solid Tumors: A Phase I Clinical Study.

Authors:  An-Wen Xiong; Jue-Min Fang; Sheng-Xiang Ren; Wei Li; Jing Wang; Yu Zhao; Guo-You Chen; Qing Xu; Cai-Cun Zhou
Journal:  Front Oncol       Date:  2021-11-05       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.